These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Comparative study of the physiological availability of 2 oral formulations of diazepam]. Dugal R; Caillé G; Brodeur J; Cooper S; Besner JG Union Med Can; 1973 Aug; 103(8):1744-8. PubMed ID: 4792864 [No Abstract] [Full Text] [Related]
4. Proceedings: Bio availability of digoxin and derivatives. Rietbrock N; Guggenmos J Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R80. PubMed ID: 4276634 [No Abstract] [Full Text] [Related]
5. Bioavailability: some pharmaceutical factors. Fowle AS Trans Med Soc Lond; 1975; 91():23-32. PubMed ID: 1236035 [No Abstract] [Full Text] [Related]
6. Recent changes in biological availability of digoxin. Effect of an alteration in 'Lanoxin' tablets. Shaw TR; Howard MR; Hamer J Br Heart J; 1974 Jan; 36(1):85-9. PubMed ID: 4818143 [No Abstract] [Full Text] [Related]
7. Determination of bioavailability of diazepam in various formulations from steady state plasma concentration data. Berlin A; Siwers B; Agurell S; Hiort A; Sjöqvist F; Ström S Clin Pharmacol Ther; 1972; 13(5):733-44. PubMed ID: 5053815 [No Abstract] [Full Text] [Related]
9. [Biopharmacy. Note IV. Influence of the technologic process and bile salts on the biopharmaceutic parameters in vitro of flufenamic acid in tablets]. Arias I; Cadorniga R Boll Chim Farm; 1974 Feb; 113(2):82-90. PubMed ID: 4848139 [No Abstract] [Full Text] [Related]
10. Scheele lecture. Biopharmaceutical aspects of drug formulation. Davis SS Acta Pharm Suec; 1986; 23(5):305-14. PubMed ID: 3565033 [No Abstract] [Full Text] [Related]
11. Proceedings: Influence of formulation on absorption and clinical effect of digoxin. Shaw TR; Howard MR; Hamer J Br Heart J; 1974 Apr; 36(4):400. PubMed ID: 4841478 [No Abstract] [Full Text] [Related]
12. Letter: Digoxin and the APhA bioavailability project. Colaizzi JL J Am Pharm Assoc; 1973 Nov; 13(11):603. PubMed ID: 4757466 [No Abstract] [Full Text] [Related]
13. [Biopharmacy and pharmacopoeias]. Mirimanoff A Pharm Acta Helv; 1971 Mar; 46(3):129-33. PubMed ID: 5550116 [No Abstract] [Full Text] [Related]
15. [Biopharmaceutical aspects of parenteral drug formulations]. Pflegel H Pharmazie; 1982 Apr; 37(4):307-18. PubMed ID: 7048344 [No Abstract] [Full Text] [Related]
16. [The biological availability of several digoxin preparations used in the Netherlands]. Dunning AJ; Buurke EJ; Roos JC; Paalman AC; van Rooy HH Ned Tijdschr Geneeskd; 1973 Dec; 117(48):1809-16. PubMed ID: 4788673 [No Abstract] [Full Text] [Related]
17. Formulation of diazepam containing rectal suppositories and experiences of their biopharmaceutical study. Regdon G; Bácskay I; Kata M; Selmeczi B; Szikszay M; Sánta A; Bálint GS Pharmazie; 1994 May; 49(5):346-9. PubMed ID: 8016180 [TBL] [Abstract][Full Text] [Related]
18. [Biopharmaceutics and drug formulation]. Riccieri FM Ann Ist Super Sanita; 1982; 18(3):541-6. PubMed ID: 7187842 [No Abstract] [Full Text] [Related]
19. The desorption of medicinal substances from adsorbents in oral pharmaceutical suspensions. Münzel K Acta Pharmacol Toxicol (Copenh); 1971; 29 Suppl 3():81-7. PubMed ID: 5316413 [No Abstract] [Full Text] [Related]